Founded in 2016, Truepill’s unique B2B model builds direct-to-patient experiences across the entire healthcare ecosystem, working with health plans, pharmaceutical manufacturers and consumer health brands alike.
An URAC-accredited company, Truepill is transforming traditional healthcare with industry-first API technology, nationwide pharmacy fulfillment and delivery services, a US-based network of licensed telehealth practitioners, white label product design and more.
Truepill’s technologies and services are built to scale with every customer; its pharmacies have the capacity to deliver 100,000 prescriptions per day, and its U.S.-based network of licensed physicians and nurse practitioners can diagnose and prescribe across 50 states. Truepill customers include: GoodRx, TherapeuticsMD, K Health, hims & hers, Nurx, Simple Health and more.
Truepill’s licensed US pharmacies offer shipping to all 50 states – filling cash and insurance-based medications. Locations include:
- Hayward, CA
- Brooklyn, NY
- Austin, TX
- Redmond, WA
- Miami, FL
- Alhambra, CA
- Manchester, UK
Truepill followed-up a July 2020, $25 million Series B funding round with a recent $75 million round led by Oak HC/FT. Truepill says the funds will help it launch an at-home lab network in partnership with “trusted third parties,” enabling it to diagnose and treat diseases alongside existing telehealth programs and pharmacies.
Truepill’s business-to-business (B2B) telemedical platform enables health care brands to deliver medication, birth control, and other prescription pills directly to customers’ doorsteps via standard mail. Truepill’s APIs provide programmatic access to its online pharmacy, while its packaging warehouses leverage robotic cells and other automation technologies to handle prescription orders.
Takeaway: Truepill recently launched Truepill Health, which connects a team of 9,000 U.S. physicians with patients through real-time video, undergirded by an in-house electronic medical record system